MUC16 and cutaneous mastocytosis: Amongst those with neither MUC16 or TTN mutations, ALM patients had the greatest number of total mutations, followed by MUP patients and then CM patients (61 ± 45 vs. 47 ± 54 vs. 34 ± 44; p < 0.001) (Table 4).